n-benzyladriamycin-14-valerate has been researched along with Leukemia L 1210 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ganapathi, R; Grabowski, D; Israel, M; Seshadri, R; Sweatman, TW | 1 |
1 other study(ies) available for n-benzyladriamycin-14-valerate and Leukemia L 1210
| Article | Year |
|---|---|
N-benzyladriamycin-14-valerate versus progressively doxorubicin-resistant murine tumours: cellular pharmacology and characterisation of cross-resistance in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Biotransformation; Cell Survival; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Female; In Vitro Techniques; Leukemia L1210; Male; Melanoma, Experimental; Mice; Mice, Inbred Strains; Time Factors | 1989 |